ANTICANCER DRUGS

Brand Owner (click to sort) Address Description
AMSINE BRISTOL-MYERS COMPANY New York NY Anticancer Drugs;
CEFEX BRISTOL-MYERS COMPANY New York NY Anticancer Drugs;
LAMASINE BRISTOL-MYERS COMPANY New York NY Anticancer Drugs;
OSALEUKIN TMRC Co., Ltd. 4-3, Akasaka 3-chome Minato-ku; Tokyo 107-0052 Japan Anticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne;
PHARMA DYNAMICS Pharma Dynamics Gesellschaft fur Konzept und Vertrieb GmbH Olendeelskoppel 36 D-22398 Hamburg Germany anticancer drugs, immunotherapeutic drugs, drugs in the field of endocrinology, pharmaceutical preparations for use in anticancer, immunotherapeutic and endocrinological fields in the form of transdermal patches and oral formulations for sustained and/or controlled release of the preparations, and anticancer diagnostic substances;technical and scientific consultation in the fields of pharmacology and medicine, consultation in medical regulatory affairs and medical industrial research services;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The use of radio-labeled antitumor drugs in the treatment of solid tumors by the method of administering a radio-labeled anticancer drug to a patient and imaging at least a part of the patient using Positron Emission Tomography imaging is described. The method can be used to monitor delivery of antitumor drugs to tumors, to predict the effectiveness of therapy with a particular antitumor drug or combination of antitumor drugs, to assess the effectiveness of modulators of cellular accumulation, to individualize therapy and to evaluate the effectiveness of antitumor drugs with respect to particular cancers. Particularly preferred drugs are labeled taxanes, e.g.,